HEADER ISOMERASE 11-SEP-09 2KO7 TITLE SOLUTION STRUCTURE OF PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FROM TITLE 2 BURKHOLDERIA PSEUDOMALLEI COMPLEXED WITH CYCLOHEXIMIDE-N- TITLE 3 ETHYLETHANOATE COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEPTIDYL-PROLYL CIS-TRANS ISOMERASE; COMPND 3 CHAIN: A; COMPND 4 EC: 5.2.1.8; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BURKHOLDERIA PSEUDOMALLEI; SOURCE 3 ORGANISM_COMMON: PSEUDOMONAS PSEUDOMALLEI; SOURCE 4 ORGANISM_TAXID: 28450; SOURCE 5 GENE: FBP, BPSS1823; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR: RIL KEYWDS CIS-TRANS ISOMERASE, FKBP, CYCLOHEXIMIDE-N-ETHYLETHANOATE, COMPLEX, KEYWDS 2 ISOMERASE, ROTAMASE, STRUCTURAL GENOMICS, SSGCID, SEATTLE STRUCTURAL KEYWDS 3 GENOMICS CENTER FOR INFECTIOUS DISEASE EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR S.ZHENG,T.LEEPER,G.VARANI,SEATTLE STRUCTURAL GENOMICS CENTER FOR AUTHOR 2 INFECTIOUS DISEASE (SSGCID) REVDAT 4 01-MAY-24 2KO7 1 REMARK SEQADV REVDAT 3 02-NOV-11 2KO7 1 JRNL VERSN REVDAT 2 06-OCT-09 2KO7 1 AUTHOR REVDAT 1 29-SEP-09 2KO7 0 JRNL AUTH I.H.NORVILLE,K.O'SHEA,M.SARKAR-TYSON,S.ZHENG,R.W.TITBALL, JRNL AUTH 2 G.VARANI,N.J.HARMER JRNL TITL THE STRUCTURE OF A BURKHOLDERIA PSEUDOMALLEI JRNL TITL 2 IMMUNOPHILIN-INHIBITOR COMPLEX REVEALS NEW APPROACHES TO JRNL TITL 3 ANTIMICROBIAL DEVELOPMENT. JRNL REF BIOCHEM.J. V. 437 413 2011 JRNL REFN ISSN 0264-6021 JRNL PMID 21574961 JRNL DOI 10.1042/BJ20110345 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CYANA 2.1 REMARK 3 AUTHORS : P.GUNTERT ET AL. REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2KO7 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 18-SEP-09. REMARK 100 THE DEPOSITION ID IS D_1000101364. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 7.0 REMARK 210 IONIC STRENGTH : 100 REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 0.6~1.2 MM [U-100% 13C; U-100% REMARK 210 15N] ENTITY_1-1, 95% H2O/5% D2O; REMARK 210 0.6~1.2 MM [U-100% 15N] ENTITY_1- REMARK 210 2, 95% H2O/5% D2O; 0.6~1.2 MM [U- REMARK 210 100% 13C; U-100% 15N] ENTITY_1-3, REMARK 210 100% D2O; 0.6~1.2 MM [U-100% REMARK 210 15N] ENTITY_1-4, 100% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 3D HNCA; 3D HNCACB; 3D REMARK 210 CBCA(CO)NH; 3D HN(CO)CA; 2D 1H- REMARK 210 1H NOESY; 3D 1H-15N NOESY; 3D 1H- REMARK 210 15N TOCSY REMARK 210 SPECTROMETER FIELD STRENGTH : 500 MHZ; 600 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NMRPIPE, CCPNMR ANALYSIS REMARK 210 METHOD USED : DISTANCE GEOMETRY REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 ASP A 48 126.86 -174.54 REMARK 500 1 ASN A 54 66.32 63.56 REMARK 500 1 ASP A 55 144.85 -176.76 REMARK 500 1 MET A 65 59.95 -154.53 REMARK 500 1 ALA A 98 24.35 -150.02 REMARK 500 2 SER A 23 62.98 61.11 REMARK 500 2 PHE A 47 12.13 -140.59 REMARK 500 2 ASP A 48 126.17 -177.73 REMARK 500 2 ASP A 55 79.66 -111.70 REMARK 500 2 PHE A 59 -177.20 -171.33 REMARK 500 2 ASP A 116 142.41 -173.04 REMARK 500 3 MET A 5 37.51 -95.78 REMARK 500 3 ASP A 48 127.49 -176.73 REMARK 500 3 PRO A 56 -177.86 -69.75 REMARK 500 3 MET A 65 61.19 -155.49 REMARK 500 3 ALA A 98 -62.73 -150.35 REMARK 500 3 VAL A 101 39.28 -94.06 REMARK 500 4 MET A 5 75.27 -102.11 REMARK 500 4 GLU A 21 171.25 -52.85 REMARK 500 4 SER A 23 63.61 62.97 REMARK 500 4 ASP A 48 127.01 -177.01 REMARK 500 4 MET A 65 21.17 -144.37 REMARK 500 4 ALA A 98 -47.69 -152.52 REMARK 500 5 PRO A 2 86.17 -69.74 REMARK 500 5 ASP A 55 145.34 -176.26 REMARK 500 5 MET A 65 67.62 -161.17 REMARK 500 5 ALA A 98 -64.03 -143.76 REMARK 500 5 VAL A 101 39.51 -93.75 REMARK 500 5 ASP A 116 148.53 -170.57 REMARK 500 6 THR A 20 119.41 -160.46 REMARK 500 6 ASP A 55 145.15 -173.59 REMARK 500 6 GLN A 75 40.23 -90.23 REMARK 500 7 PRO A 2 91.79 -69.76 REMARK 500 7 SER A 23 73.61 53.63 REMARK 500 7 ASP A 48 132.52 -171.52 REMARK 500 7 ASP A 55 144.51 -177.09 REMARK 500 7 ALA A 98 24.38 -149.26 REMARK 500 8 THR A 20 119.85 -160.21 REMARK 500 8 PHE A 47 22.22 -141.37 REMARK 500 8 ASP A 48 126.97 -177.42 REMARK 500 8 ASP A 55 144.23 -179.77 REMARK 500 9 SER A 23 85.69 63.15 REMARK 500 9 ASP A 48 127.02 -176.67 REMARK 500 10 THR A 20 116.23 -160.40 REMARK 500 10 ASN A 54 69.35 63.42 REMARK 500 10 ASP A 55 144.63 -170.40 REMARK 500 10 MET A 65 68.07 -151.72 REMARK 500 10 ALA A 98 -67.15 -150.58 REMARK 500 10 VAL A 101 39.58 -93.76 REMARK 500 11 THR A 20 115.28 -160.52 REMARK 500 REMARK 500 THIS ENTRY HAS 105 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE JZF A 130 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: BUPSA.00130.A RELATED DB: TARGETDB DBREF 2KO7 A 5 117 UNP Q63J95 Q63J95_BURPS 1 113 SEQADV 2KO7 GLY A 1 UNP Q63J95 EXPRESSION TAG SEQADV 2KO7 PRO A 2 UNP Q63J95 EXPRESSION TAG SEQADV 2KO7 GLY A 3 UNP Q63J95 EXPRESSION TAG SEQADV 2KO7 SER A 4 UNP Q63J95 EXPRESSION TAG SEQRES 1 A 117 GLY PRO GLY SER MET THR VAL VAL THR THR GLU SER GLY SEQRES 2 A 117 LEU LYS TYR GLU ASP LEU THR GLU GLY SER GLY ALA GLU SEQRES 3 A 117 ALA ARG ALA GLY GLN THR VAL SER VAL HIS TYR THR GLY SEQRES 4 A 117 TRP LEU THR ASP GLY GLN LYS PHE ASP SER SER LYS ASP SEQRES 5 A 117 ARG ASN ASP PRO PHE ALA PHE VAL LEU GLY GLY GLY MET SEQRES 6 A 117 VAL ILE LYS GLY TRP ASP GLU GLY VAL GLN GLY MET LYS SEQRES 7 A 117 VAL GLY GLY VAL ARG ARG LEU THR ILE PRO PRO GLN LEU SEQRES 8 A 117 GLY TYR GLY ALA ARG GLY ALA GLY GLY VAL ILE PRO PRO SEQRES 9 A 117 ASN ALA THR LEU VAL PHE GLU VAL GLU LEU LEU ASP VAL HET JZF A 130 55 HETNAM JZF ETHYL (4-{(2R)-2-[(1S,3S,5S)-3,5-DIMETHYL-2- HETNAM 2 JZF OXOCYCLOHEXYL]-2-HYDROXYETHYL}-2,6-DIOXOPIPERIDIN-1- HETNAM 3 JZF YL)ACETATE FORMUL 2 JZF C19 H29 N O6 HELIX 1 1 LYS A 51 ARG A 53 5 3 HELIX 2 2 ILE A 67 GLN A 75 1 9 HELIX 3 3 PRO A 88 GLY A 92 5 5 SHEET 1 A 6 VAL A 8 THR A 9 0 SHEET 2 A 6 LYS A 15 THR A 20 -1 O TYR A 16 N VAL A 8 SHEET 3 A 6 VAL A 82 ILE A 87 -1 O VAL A 82 N THR A 20 SHEET 4 A 6 LEU A 108 ASP A 116 -1 O PHE A 110 N LEU A 85 SHEET 5 A 6 THR A 32 LEU A 41 -1 N TRP A 40 O VAL A 109 SHEET 6 A 6 LYS A 46 SER A 49 -1 O PHE A 47 N GLY A 39 SHEET 1 B 6 VAL A 8 THR A 9 0 SHEET 2 B 6 LYS A 15 THR A 20 -1 O TYR A 16 N VAL A 8 SHEET 3 B 6 VAL A 82 ILE A 87 -1 O VAL A 82 N THR A 20 SHEET 4 B 6 LEU A 108 ASP A 116 -1 O PHE A 110 N LEU A 85 SHEET 5 B 6 THR A 32 LEU A 41 -1 N TRP A 40 O VAL A 109 SHEET 6 B 6 PHE A 57 VAL A 60 -1 O PHE A 57 N VAL A 35 SITE 1 AC1 6 ASP A 48 MET A 65 ILE A 67 TRP A 70 SITE 2 AC1 6 TYR A 93 PHE A 110 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1